X4 Pharmaceuticals (XFOR) Price/Book Ratio

Price: $4.35
Market Cap: $25.18M
Avg Volume: 76.08K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.581
52W Range: $4.17-36
Website: X4 Pharmaceuticals

What is X4 Pharmaceuticals's Price/Book Ratio?

  • X4 Pharmaceuticals's trailing twelve month (TTM) Price/Book ratio is 1184.64.
  • X4 Pharmaceuticals's annual Price/Book ratio as of today is 5994.01.
  • X4 Pharmaceuticals's quarterly Price/Book ratio is 5994.01.

What is the Price/Book Ratio?

The Price/Book (P/B) ratio is a financial metric that compares a company's market value to its book value. It is calculated by dividing the company's stock price by its book value per share. A lower P/B ratio may indicate that the stock is undervalued.

How is the Price/Book Ratio Calculated?

P/B Ratio = (Market Price per Share) / (Book Value per Share)

Related Metrics

Other important metrics to assess X4 Pharmaceuticals's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -3545.03
    • Quarterly: -833.49
    • TTM: -700.63
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 51920.76
    • Quarterly: 92581.16
    • TTM: 9.85
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -1014.21
    • Quarterly: -4023.68
    • TTM: -200.45
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the ratio of the P/E ratio to the company's expected earnings growth rate:
    • Annual: 52.62
    • Quarterly: -101.69
    • TTM: 5.77

These metrics provide insights into X4 Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Book Ratio

5994.01

Quarterly Price/Book Ratio

5994.01

TTM Price/Book Ratio

1184.64

X4 Pharmaceuticals Historical Price/Book Ratio
6000.006000.004000.004000.002000.002000.000.000.00-2000.00-2000.00-4000.00-4000.00Price/Book Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/E Ratio
0.000.00-1000.00-1000.00-2000.00-2000.00-3000.00-3000.00-4000.00-4000.00-5000.00-5000.00-6000.00-6000.00P/E Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/S Ratio
60000.0060000.0050000.0050000.0040000.0040000.0030000.0030000.0020000.0020000.0010000.0010000.000.000.00P/S Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/C Ratio
0.000.00-2000.00-2000.00-4000.00-4000.00-6000.00-6000.00-8000.00-8000.00P/C Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical PEG Ratio
60.0060.0030.0030.000.000.00-30.00-30.00-60.00-60.00PEG Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025

X4 Pharmaceuticals Historical Ratios

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Price/Book Ratio P/E Ratio P/S Ratio P/C Ratio PEG Ratio
2024 5994.01 -3545.03 51920.76 -1014.21 52.62
2023 2626.53 -1326.65 0.00 -1390.63 21.59
2022 766.68 -604.83 0.00 -736.34 10.96
2021 823.89 -598.32 0.00 -748.45 -59.83
2020 1595.98 -1870.01 38728.53 -1975.34 49.87
2019 859.26 -1961.59 0.00 -2310.56 24.30
2018 996.38 -500.27 6149.11 -526.17 6.69
2017 403.33 -698.95 0.00 -849.57 -2.36
2016 -1243.02 -3060.18 0.00 -3249.11 -39.95
2015 -2048.47 -5319.08 0.00 -6500.33 0.00

Related Metrics

Explore detailed financial metrics and analysis for XFOR.